HMG-CoA Reductase Inhibitors Are Associated with Decreased Serum Neopterin Levels in Stable Coronary Artery Disease

Verfasser / Beitragende:
[Roland B. Walter, Dietmar Fuchs, Günter Weiss, Thomas R. Walter, Walter H. Reinhart]
Ort, Verlag, Jahr:
2003
Enthalten in:
Clinical Chemistry and Laboratory Medicine, 41/10(2003-09-19), 1314-1319
Format:
Artikel (online)
ID: 378849476
LEADER caa a22 4500
001 378849476
003 CHVBK
005 20180305123320.0
007 cr unu---uuuuu
008 161128e20030919xx s 000 0 eng
024 7 0 |a 10.1515/CCLM.2003.200  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/CCLM.2003.200 
245 0 0 |a HMG-CoA Reductase Inhibitors Are Associated with Decreased Serum Neopterin Levels in Stable Coronary Artery Disease  |h [Elektronische Daten]  |c [Roland B. Walter, Dietmar Fuchs, Günter Weiss, Thomas R. Walter, Walter H. Reinhart] 
520 3 |a Neopterin, a marker of stimulated cellular immune response, is increased in unstable angina, acute myocardial infarction and possibly stable coronary artery disease. 3-Hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase inhibitors (statins) have antiinflammatory properties, but their effect on neopterin largely unknown. Neopterin was measured in 232 patients undergoing elective coronary angiography and compared to the degree of atherosclerosis, use of concomitant medications and demographics. Neopterin was lower in subjects using statins (n = 66) compared to those not taking statins (median (range): 6.65 (4.1-18.3) vs. 7.70 (3.6-29.1) nmol/l, p < 0.0001). This association was also found in the subgroup of patients with coronary artery disease (1-3-vessel disease, n = 164; 6.60 (4.1-18.3) vs. 7.80 (3.6-29.1) nmol/l, p = 0.0012), whereas only a slight tendency toward lower neopterin levels was found in the group without atherosclerosis (6.90 (5.1-16.0) vs. 7.60 (4.0-18.5) nmol/l, p = 0.17). In patients with coronary atherosclerosis, neopterin concentrations were lower in smokers (n = 105) compared to nonsmokers (7.20 (3.6-29.1) vs. 7.90 (4.4-18.6) nmol/l, p < 0.02), confirming previous observations. However, use of statins was associated with lower neopterin levels in both nonsmokers and smokers (6.70 (4.1-18.3) vs. 7.60 (3.6-29.1) nmol/l, p < 0.05, and 6.20 (5.2-16.0) vs. 7.80 (4.4-18.6) nmol/l, p < 0.05, respectively). Overall, similar serum neopterin concentrations were found in patients with coronary atherosclerosis and those without. In accordance with their antiinflammatory effects, the use of statins is associated with lower neopterin levels in patients undergoing elective coronary angiography. Clin Chem Lab Med 2003; 41(10):13141319 
540 |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Medical equipment & techniques  |2 nationallicence 
690 7 |a Medical diagnosis  |2 nationallicence 
690 7 |a Diseases & disorders  |2 nationallicence 
700 1 |a Walter  |D Roland B.  |4 aut 
700 1 |a Fuchs  |D Dietmar  |4 aut 
700 1 |a Weiss  |D Günter  |4 aut 
700 1 |a Walter  |D Thomas R.  |4 aut 
700 1 |a Reinhart  |D Walter H.  |4 aut 
773 0 |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 41/10(2003-09-19), 1314-1319  |x 1434-6621  |q 41:10<1314  |1 2003  |2 41  |o cclm 
856 4 0 |u https://doi.org/10.1515/CCLM.2003.200  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/CCLM.2003.200  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Walter  |D Roland B.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Fuchs  |D Dietmar  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Weiss  |D Günter  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Walter  |D Thomas R.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Reinhart  |D Walter H.  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 41/10(2003-09-19), 1314-1319  |x 1434-6621  |q 41:10<1314  |1 2003  |2 41  |o cclm 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter